关注
Lindsay M. LaFave
Lindsay M. LaFave
其他姓名Lindsay M. Saunders
Assistant Professor, Albert Einstein College of Medicine
在 einsteinmed.org 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Chromatin potential identified by shared single-cell profiling of RNA and chromatin
S Ma, B Zhang, LM LaFave, AS Earl, Z Chiang, Y Hu, J Ding, A Brack, ...
Cell 183 (4), 1103-1116. e20, 2020
7032020
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression
O Abdel-Wahab, M Adli, LM LaFave, J Gao, T Hricik, AH Shih, S Pandey, ...
Cancer cell 22 (2), 180-193, 2012
6912012
Loss of the tumor suppressor BAP1 causes myeloid transformation
A Dey, D Seshasayee, R Noubade, DM French, J Liu, MS Chaurushiya, ...
Science 337 (6101), 1541-1546, 2012
4402012
Loss of BAP1 function leads to EZH2-dependent transformation
LM LaFave, W Béguelin, R Koche, M Teater, B Spitzer, A Chramiec, ...
Nature medicine 21 (11), 1344-1349, 2015
3662015
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
O Abdel-Wahab, J Gao, M Adli, A Dey, T Trimarchi, YR Chung, C Kuscu, ...
Journal of Experimental Medicine 210 (12), 2641-2659, 2013
3652013
Epigenomic state transitions characterize tumor progression in mouse lung adenocarcinoma
LM LaFave, VK Kartha, S Ma, K Meli, I Del Priore, C Lareau, S Naranjo, ...
Cancer cell 38 (2), 212-228. e13, 2020
1802020
Spatial genomics enables multi-modal study of clonal heterogeneity in tissues
T Zhao, ZD Chiang, JW Morriss, LM LaFave, EM Murray, I Del Priore, ...
Nature 601 (7891), 85-91, 2022
1472022
JAK2 the future: therapeutic strategies for JAK-dependent malignancies
LM LaFave, RL Levine
Trends in pharmacological sciences 33 (11), 574-582, 2012
1102012
Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung
CP Concepcion, S Ma, LM LaFave, A Bhutkar, M Liu, LP DeAngelo, ...
Cancer discovery 12 (2), 562-585, 2022
662022
Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesis
SC Meyer, MD Keller, BA Woods, LM LaFave, L Bastian, M Kleppe, ...
Blood, The Journal of the American Society of Hematology 124 (14), 2280-2284, 2014
542014
Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform
S Naranjo, CM Cabana, LM LaFave, R Romero, SL Shanahan, A Bhutkar, ...
Genes & Development 36 (15-16), 936-949, 2022
172022
Protocol for single-cell ATAC sequencing using combinatorial indexing in mouse lung adenocarcinoma
I Del Priore, S Ma, J Strecker, T Jacks, LM LaFave, JD Buenrostro
STAR protocols 2 (2), 100583, 2021
132021
Single-cell epigenomics reveals mechanisms of cancer progression
LM LaFave, RE Savage, JD Buenrostro
Annual Review of Cancer Biology 6 (1), 167-185, 2022
112022
Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"
LM LaFave, W Béguelin, R Koche, M Teater, B Spitzer, A Chramiec, ...
Nature medicine 22 (6), 578-579, 2016
112016
Targeting a regulator of protein homeostasis in myeloproliferative neoplasms
LM LaFave, RL Levine
Nature Medicine 22 (1), 20-21, 2016
92016
Mining the epigenetic landscape in ALL
LM LaFave, RL Levine
Nature genetics 45 (11), 1269-1270, 2013
72013
Evolution of OncoKB, a precision oncology knowledgebase
SP Suehnholz, R Kundra, H Zhang, S Smith, M Nissan, Y Yao, L LaFave, ...
Cancer Research 81 (13_Supplement), 99-99, 2021
32021
Unlocking PDAC initiation with AP-1
LM LaFave, JD Buenrostro
Nature Cancer 2 (1), 14-15, 2021
22021
Research vision workshopping: Peer mentoring to support the transition to independence
NS Bayin, KL McKinley, LM LaFave
Cell 186 (7), 1295-1299, 2023
12023
Annotation of somatic genomic variants in hematologic diseases using oncokb, a precision oncology knowledgebase
SP Suehnholz, R Kundra, M Roshal, W Xiao, K Petrova-Drus, M Yabe, ...
Blood 134, 2148, 2019
12019
系统目前无法执行此操作,请稍后再试。
文章 1–20